chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was seated in chair for observation. About 10min after injection pt's head hit wall and he was noted to be very pale and did not appear well. Patient was lowered to the ground and rapid response team was called to evaluate. Patient's vitals were abnormal- low heart rate and blood pressure. Patient denied any swelling of mouth or throat or trouble breathing, Patient transferred to emergency department.
3/28/21: Headache, Nausea, Fatigue until 3/29/21 went back to feeling normal.   4/17/21-4/19/21: Nauseous, Fatigue constantly throughout those days.   4/25/21: Fainted out of nowhere, taken to Hospital in ambulance. Headache and Nausea returned after coming to as well as fatigue. Only now symptoms were much severe and constant.   4/25/21-5/04/21: Fatigue, nausea have been much worse. Haven?t gone to work this whole week. Went back to ER midnight of 5/04/21 because of nausea and fatigue very severe.
Husband states wife was sick after shots & her (R) arm hurt to be touched. Red spots Sat, took to ER. States treated for cellulitis Sat & Sun in ER by IV. Thur - she cont. to get worse till Sat then to ER - tx in ER - 10/26/11 - still (L) arms hurt. Temp 101 degrees - Thur -> Sat. Sat - Mon IV antibiotics.
I noticed a granuloma annulare on my right breast.  I have no pain/itching or irritation.  There are no other marks on my body and I do not have a history of this.  I read this could be possibly related to the COVID Pfizer vaccine so I felt I should report. I also reported this on the Pfizer site.
Main concern was my baby's heartrate.. after receiving about 48 hours the baby heart rate was down..  the heart rate was down to 10.. I was sent home with close monitoring and after a few days the baby's heartrate finally was normal. I am told that I cannot get the second dose until after I give birth .  My estimated date of delivery is February 8th 2021 I had flu like symptoms ,
Pt stated he had a history of passing out after vaccination. Pt placed in chair for vaccination. Post vaccination pt had loss of color in his face. Pt leaned forward stating he was dizzy. Pt tensed with muscles contracted forward, eyes glassed over and vocalized a cooing sound. Pt maintained contracted position for aprox 30 seconds. Pt reoriented on day and place. Pt answered appropriately. Pt questioned if he has ever had a seizure before, which he stated he did. Pt instructed to stay seated while we requested for Dr. assessment. Pt stated he felt as though he was getting dizzy again, as he went into the same episode, again lasting aprox 30 seconds, which he was reoriented again post episode.
COVID VACCINE (PFIZER, 6 months to 4 yrs) WAS NOT RECONSTITUTED AND CHILD WAS GIVEN 0.2 ML OF UNDILUTED VACCINE.
Extreme pain in all extremities, weight loss, weakness all extremities, loss of all reflexes, debilitating headaches 1/15/12 -> present.
Information has been received from a 70 year old consumer with an unspecified blood pressure and thyroid disorder, and an allergy to monosodium glutamate who on 03-DEC-2007, received a 0.65 ml, intramuscular dose of Zostavax (Oka/Merck).  Concomitant therapy included unspecified medication for "blood pressure", and an unspecified medication for "thyroid".  She indicated that on an unspecified date since receiving the vaccine, she developed a cold, and unspecified bronchial problems.  Current patient status was not reported.  A product quality complaint was not reported.  This is one of two of two from the same source.  Follow up information has been requested.
Swelling, itchy, redness soreness to site L deltoid.  Expanding to 15CM down deltoid muscle.  Blanching throughout both upper extremities.  Likely a allergic reaction.  Patient reports same reaction to each anthrax vaccine previous.
red, swollen, hot to the touch, all local reaction symtoms; red, swollen, hot to the touch, all local reaction symtoms; red, swollen, hot to the touch, all local reaction symtoms; red, swollen, hot to the touch, all local reaction symtoms; Initial information received on 19-Sep-2019 regarding an unsolicited valid non-serious case received from a non-health care professional.  This case involves A female patient of unknown age who experienced red, swollen, hot to the touch, all local reaction symptoms (vaccination site inflammation, vaccination site warmth, vaccination site erythema, vaccination site swelling) while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication not reported.   On an unknown date, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (prefilled syringe) lot UT6647KA via unknown route in unknown administration site.  On an unknown date, the patient developed red, swollen, hot to the touch, all local reaction symptoms (vaccination site inflammation), (vaccination site warmth), (vaccination site erythema) and (vaccination site swelling) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Details of lab data not reported.  Final diagnosis was red, swollen and hot to the touch, all local reaction symptoms.   It was not reported if the patient received any corrective treatment.  At the time of reporting, event outcome was not reported.  List of documents held by sender: none.
I am only reporting this, as it seems to be a newer side effect that is being discovered.  The date of my second vaccine, i felt my energy level drop a few hours after the injection.  I increased fluids, and reduced my work.  The next day i was extremely tired, the lymph node over my left clavicle was sore, and lots of body aches, (i was not surprised by this.)  On Monday i was expecting to feel better, however my energy level was still very low, and i have a fogginess to my brain, almost as if I was slightly inebriated.  I stayed home from work on Monday.  I am at work on Tuesday, 5/11, however I still feel like i have 40-50% brain function.  I do not see this as a serious side effect, but wanted to report if it is helpful for data collection.
Information has been received from a Physician's Assistant (PA) concerning a female patient with a known phenol allergy who in November 2005, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine.  In November 2005, the patient developed an injection site reaction because of the phenol allergy.  The phenol allergy was known before the injection was given.  Medical attention was sought.  The patient's outcome was unknown.  Follow up information has been received from the PA concerning the 85 year old white retired female with aortic aneurysm, hypertension, hyponatremia, osteoporosis, knee pain, pelvic pain, urinary tract infection (25-oct-2005), and allergies to sulfonamides, pseudoephedrine hydrochloride (SUDAFED), ampicillin, and rofecoxib (MSD), AND A HISTORY OF DYSURIA (12-SEP-2005), concussion with no loss of consciousness (10-MAR-2005), abrasion or friction burn of elbow without infection, and hematuria who in the morning of 01-NOV-2005 was vaccinated intramuscularly in right deltoid with her first dose of pneumococcal 23v polysaccharide vaccine (lot#650302/1039P).  Concomitant therapy included aspirin, sulfamethaxazole/trimethoprim (BACTRIM DS tablets), calcium (unspecified), alendronate sodium (+) cholecalciferol (MSD), ciprofloxacin hydrochloride (CIPRO), cephalexin (KEFLEX), metoprolol tartrate (LOPRESSOR), HCTZ/TRIAMTERENE (MAXZIDE), vitamins (unspecified), amlodipine besylate (NORVASC), levothyroxine Na (SYTHROID), acetaminophen/hydrocodone bitartrate (VICODIN tablets), vitamin D (unspecified), and vitamin E. It was reported that on the morning of 02-NOV-2005 the patient developed cellulitis with pain, redness, and edema.  She was placed on cephalexin (KEFLEX) 500 mg capsule, 1 capsule by mouth three times a day for seven days, and fexofenadine hydrochloride (ALLERGA) 180 mg tablet, 180 mg daily.  On recheck on 09-NOV-2005, the symptoms had resolved.  No further information is available.
Four to five minutes after receiving immunizations child became limp and unresponsive lasting 30 secs.  Then body became rigid, arching back, extremities, shaking and passing gas.  Lasting 30 to 40 seconds.  Patient was responsive to sharp pain to head and weak.
Patient developed a Lipschulz ulcer after her 2nd dose of Pfizer covid vaccine in June 2021. She received her booster shot on 01/19/2022 and developed another Lipschulz ulcer 2 days later. The ulcer is very painful and is being treated with NSAID, & sitz bath.
Achy on covid vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy on covid vaccine.) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ulcerative colitis.    Concurrent medical conditions included Ulcerative colitis (Moderate to severe ).   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PAIN (Achy on covid vaccine.). At the time of the report, PAIN (Achy on covid vaccine.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. On unknown date, the patient experienced reaction to Humira syringe. No treatment medication reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  The reporter's causality for the event(s) of reaction to Humira syringe and achy on covid vaccine with Humira(adalimumab) was no reasonable possibility.  This case was identified as part of a retrospective clean-up activity received in the Moderna were missed to be booked-in.
She had a high fever; This is a spontaneous report from a non-contactable consumer or other non hcp patient's mother).  A 13-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in arm right on 02Jun2021 (Batch/Lot Number: EW0177) as a Single dose for covid-19 immunization. The patient medical history and concomitant medication was not reported. The patient previously took BNT162B2 on 12May2021 for COVID-19 Immunization (Dose: 1st, Batch/lot number: EW0179, anatomical site of injection for first vaccination: Left arm). On 03Jun2021, She had a high fever and the fever recorded 24 hours after the shot. The patient mother was interesting to patient about the fever was recorded 24 hours after the shot. So first she thought the patient didn't go to have any side effects at all but then she did get side effects 24 hours after the shot." The patient did not take any vaccination prior to second vaccination. The patient took Ibuprofen for fever reducing medicine. The outcome of the event was recovered in Jun2021.   No follow-up attempts are possible. No further information is expected.
Myalgia, UrticariaPruritus, Erythema, warmth and swelling of arm and lymph nodes in the axilla on the same side as the injection site. Narrative:
within 10-15 minutes of injection my mouth was dry and the back of my throat started to constrict. Patient had difficulty swallowing and some wheezing. Minimal itching to chest. Benadryl 50mg taken po and symptoms went away in 1 hour.
Initial report received from Healthcare professional on 07 November 2014. A more than 65-year-old male patient, whose medical history and concomitant medications were not reported, had received an intramuscular dose of FLUZONE HD (Batch number U5063AA, expiry date 04 Jun 2015, a dose number was not reported) in the left arm on 03 November 2014. On an unspecified date, the patient had experienced large black, blue and yellowish bruise at injection site. Lab investigations and corrective treatment were not reported. The patient's illness at the time of vaccination, and pre-existing diagnosed allergies and birth defects were not reported. At the time of this report, the outcome of the event was unknown. List of documents held by sender: none.
Nausea, dizziness, fatigue, confusion, high blood pressure, tightness in chest, rapid heart beat, numbness and tingling, nerve pain, shortness of breath.
Fever 102-103 for 2 days.  Hives on post vaccine day #3.
pain in arm; mark clearly seen; This case was reported by a consumer and described the occurrence of injection site pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th August 2018, the patient received the 1st dose of Shingrix. On an unknown date, several days after receiving Shingrix, the patient experienced injection site pain and injection site scar. On an unknown date, the outcome of the injection site pain and injection site scar were not recovered/not resolved.   The reporter considered the injection site pain and injection site scar to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix on the left upper arm. Several days after receiving Shingrix, the patient began suffering from endless pain in the upper arm at the area where the shot was given with mark clearly seen. After 2 weeks, the patient reported to the pharmacist about the pain he was suffering and the pharmacist told that he would report it to regular channels. The patient updated the pharmacist at almost every 10 days and they decided to wait for few weeks in the hope that the pain will go away. The patient stated that, the pain would come and goes every 2 to 3 days, sometimes a sharp pain, sometimes for a few minutes and often for days. Since from 25th March 2019, the pain persisted and the patient was worried a lot. The pain was troubling as the patient had no way to overcome it and there was no known relief. The pain was bothering the daily life of patient.  The patient claimed that, he hold GlaxoSmithKline responsible for this adverse event and also the company must aware of this medical damage but it was hiding from public. The patient requested amicable settlement in the form of medical relief and monetary compensation for this adverse event.   Follow up information received from the consumer on 21st April 2019: The patient requested to assign a physician to examine him so that the complete information about the adverse events the patient was experiencing would be provided to GlaxoSmithKline. Or the patient would seek medical examination or help by himself and would proceed further for lawsuit.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a adult male patient who received SHINGRIX (batch number 4FS5N, expiry date 8th March 2019) for prophylaxis. On 9th October 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, 30 days after receiving SHINGRIX, the patient experienced shingles and post herpetic neuralgia. On an unknown date, the outcome of the shingles and post herpetic neuralgia were unknown. It was unknown if the reporter considered the shingles and post herpetic neuralgia to be related to SHINGRIX. Additional case details were reported as follows: Approximately one month later after vaccination, the patient developed Shingles which progressed to post herpetic neuralgia. Collected while tried to escalated an medical information (MI) questions. The reporter had to look in several different locations for the information and did not get to pull up scans. No additional details were provided.
Fever or Chills  Cough  Fatigue  Headache  Sore throat
Fever began 7 days after vaccinations, 100.4 to 102.1 rectally, lasted 3 days, tylenol and ibuprofen given for comfort. Rash (fine, pink, flat initially then slightly raised) began on trunk 9 days after vaccinations, spread to limbs and head on day 10, fading on day 11. Also he was irritable, had difficulty sleeping, and poor appetite.
Lt arm with mod. amount of swelling from elbow to should, warm to touch near injection site, mod of pain to area
Patient received the J&J vaccine on 3/10. On 3/13 he developed slurred speech, unilateral lower facial droop, weakness of extremities, generalized fatigue. On 3/15 he sought medical attention and was sent to ER -- > diagnosed w/ TIA. Pt sent back to jail where simvastatin -- > atorvastatin, pt started lisinopril, ASA. Pt denies deficits today
He was faint; Shortness of breathe; Rapid heart beat; Hungry; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (He was faint) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04021a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced SYNCOPE (He was faint) (seriousness criterion medically significant), DYSPNOEA (Shortness of breathe), HEART RATE INCREASED (Rapid heart beat) and HUNGER (Hungry). At the time of the report, SYNCOPE (He was faint), DYSPNOEA (Shortness of breathe), HEART RATE INCREASED (Rapid heart beat) and HUNGER (Hungry) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were blood pressure medications. No further information regarding names of the medications was provided. No treatment information for the events was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
On May 3 at approximately 8 am, I began having a confusional migraine which I have been having occasionally for 12 years. I became confused and dizzy and lost temporarily lost feeling in my right arm. I took 2 tablets of Aleve and went to sleep; I woke up at around 2:30 pm and the migraine was over, but I was feverish and had a headache that persisted until May 4 mid-morning
Received vaccine (mist) at 4pm on 2/2.  On 2/3 at 10:40 am, began to feel light-headed and queasy while sitting in class.  5 minutes later, fainted and fell to floor.  Dazed upon being revived.  Felt very ill for next hour (shaky, nauseaous, "numb" legs and arms [tingly, unsteady], dizzy).  At 24 hours since first reaction, continues to have sore muscles throughout body especially legs & arms, and runny nose, unsteady physically, "balloon head."
Chills (36 hours+), headache (36 hours), muscular aches (48 hours), fatigue (48 hours), difficulty breathing through mouth without sensation of need to cough (started within 10 hours and still lingers as of date of submission of this report), shortness of breath - difficulty taking a deep breath (this was frightening), fever of 102.5 (started approx 36 hours after onset of reaction but broke within 6 hours) and inflammation at injection site (hard lump, warm, pain when touched and redness started within 4 hours and still present at time of submission of this report).
Mom phoned health department, stated her daughter had immunizations yesterday.  Mom stated baby has been very irritable, has fever yet today, wont eat or drink.  She reports giving her TYLENOL every 4-6 hours since immunizations yesterday. RN encourage mom to notify physician.
Pt recv vax on 12/14/98; on 12/15/98 pt exp red, swollen, painful of vax site to neck, chest, back w/ trouble moving arm; nausea; tx=Tylenol
Found out I was pregnant Feb 11th, 2021, the day before my second dose of covid-19 vaccination.  Started bleeding February 22nd, 2021.  Went to Emergency Room and was informed may be having a miscarriage.   Persisted bleeding for a week.  Visited an OB throughout that week and verified I was going through a miscarriage and was approximately 4-5 weeks.     First pregnancy and only pregnancy.
Have had on-off fast heart rate. Assumed that this symptom was part of work stress, however the fast rate is not correlated with stressful moments at work. (Recently learned from a friend that they?ve been having other symptoms. Thought it may need to be reported.)
FEELING ITCHY ALL OVER BODY; INJECTED ARM WAS SORE; This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, smoker, and alcohol user, and other pre-existing medical conditions included the patient had history of drug abuse or illicit drug use. The patient had no medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 07-JUL-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On 07-JUL-2021, the subject experienced injected arm was sore. On 08-JUL-2021, the subject experienced feeling itchy all over body. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling itchy all over body, and the outcome of injected arm was sore was not reported. This report was non-serious.
on 1/10/21 there was mild to moderate swelling and soreness at the injection site, on 1/11/2021 swelling still present, pain resided but was very pruritic through 1/12/2021. By 1/13/2021 symptoms mostly resolved. No issues until 1/17/21 (8 days after initial vaccine) very firm swelling formed and increased throughout the day. Non responsive to NSAID, Diphenhydramine hydrocortisone cream,  and cold compress. Very pruritic. Medical attention sought at Urgent Care Facility that evening.  Treated with prescription strength topical Triamcinolone. Some improvement 24 hrs later, but still not completely resolved. Treatment is currently on going. Follow up indicated on 1/19/21 if not resolved per physician.
fever 99.5, shivering,  headache, nausea, muscle pain.  moderate swelling at injection site.
Rash starts from day 2-9 post vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash starts from day 2-9 post vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced RASH (Rash starts from day 2-9 post vaccination). At the time of the report, RASH (Rash starts from day 2-9 post vaccination) outcome was unknown.            Concomitant medications were not provided. Treatment information was not reported.
Starting the day after my second vaccine, I had heart palpitations which felt like my heart was beating very hard/skipping beats/squeezing/?glugging?. It happened intermittently a few times an hour throughout the day but I attributed it to my fever (101F). The next day my fever was gone but heart palpitations remained. They continued for the next week, albiet slightly reduced in frequency. At that point I made a dr appt. I had an EKG and wore a 24 hr holter monitor which both showed no irregularities. Now, 1.5 months after my second dose of the vaccine, the irregular beating has reduced greatly and does not impact my daily life
Chills, high fever near 102 degrees, severe tinnitus;  Treated with acetaminophen and bedrest; Fever resolved within 24 hrs, but diminished hearing and tinnitus have persisted as of this date.